# Observational Non-interventional Study (Anwendungsbeobachtung) With Aptivus® (Tipranavir) in HIV-infected Patients.

> **NCT00531206** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 65 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Tipranavir
- **DRUG:** Ritonavir

## Key facts

- **NCT ID:** NCT00531206
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2009-01
- **Final completion:** —
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2014-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00531206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00531206, "Observational Non-interventional Study (Anwendungsbeobachtung) With Aptivus® (Tipranavir) in HIV-infected Patients.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00531206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*